Vaccination and immunization is aids in prevention of diseases among adults and children. Vaccines are biological suspensions that contain an agent that resembles the disease causing microorganisms and are often made from inactivated microbes, toxins or surface proteins. The active agents present in the vaccine stimulates body’s immune system to recognize the disease causing agent as 'foreign substance' and develop antibodies against it. Vaccines are a preferable and highly recommended preventive measure against certain severe diseases, however, have mild side effects.
Market Dynamics
Development of vaccines for various new diseases and rising awareness regarding advantages of preventive medication are the two prominent factors supporting growth of the market. For instance, according to the Centers for Disease Control and Prevention, 2015, flu vaccinations prevented around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden. However, high complexity in cost of manufacturing a vaccine is one of the major factors negatively affecting growth of the market.
Key features of the study:
This report provides in-depth analysis of adult vaccines market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2017 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global adult vaccines market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study includes GlaxoSmithKline Plc, Merck & Co., Sanofi Pasteur, Pfizer, Inc., CSL Limited, Johnson & Johnson, Serum Institute of India, Medimmune, and AstraZeneca Plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global adult vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the adult vaccines market
Detailed Segmentation:
Global Adult Vaccines Market, By Vaccine:
Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others
Global Adult Vaccines Market, By Vaccine Type:
Monovalent
Multivalent
Global Adult Vaccines Market, By Technology:
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
Global Adult Vaccines Market, By Geography:
North America
By Vaccine:
Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others
By Vaccine Type:
Monovalent
Multivalent
By Technology:
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Country:
U.S.
Canada
Latin America
By Vaccine:
Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others
By Vaccine Type:
Monovalent
Multivalent
By Technology:
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Vaccine:
Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others
By Vaccine Type:
Monovalent
Multivalent
By Technology:
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Vaccine:
Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others
By Vaccine Type:
Monovalent
Multivalent
By Technology:
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Vaccine:
Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others
By Vaccine Type:
Monovalent
Multivalent
By Technology:
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Country:
GCC
Israel
Rest of Middle East
Africa
By Vaccine:
Influenza
Tetanus, Diphtheria, Pertussis (Td/Tdap)
Varicella
Human Papillomavirus
Zoster
Measles, Mumps, Rubella (MMR)
Pneumococcal
Hepatitis
Others
By Vaccine Type:
Monovalent
Multivalent
By Technology:
Live Attenuated Vaccines
Inactivated Viral/Bacterial Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
By Country:
South Africa
Central Africa
North Africa
Company Profiles
GlaxoSmithKline Plc *
Company Overview
Product Portfolio
Key Highlights
Financial Performance
Strategies
Merck & Co., Inc.
Sanofi Pasteur
Pfizer, Inc.
CSL Limited
Johnson & Johnson
Serum Institute of India
Medimmune
AstraZeneca Plc
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Vaccine
? Market Snippet, By Vaccine Type
? Market Snippet, By Technology
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Key Highlights
o Market Trends
o PEST Analysis
o Government & Non-Government Initiatives
o Epidemiology
4. Global Adult Vaccines Market, By Vaccine, 2015 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, 2016 - 2025
? Segment Trends
o Influenza
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Tetanus, Diphtheria, Pertussis (Td/Tdap)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Varicella
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Human Papillomavirus
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Zoster
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Measles, Mumps, Rubella (MMR)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Pneumococcal
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Hepatitis
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
5. Global Adult Vaccines Market, By Vaccine Type, 2015 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, 2016 - 2025
? Segment Trends
o Monovalent
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Multivalent
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
6. Global Adult Vaccines Market, By Technology, 2015 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, 2016 - 2025
? Segment Trends
o Live Attenuated Vaccines
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Inactivated Viral/Bacterial Vaccines
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Toxoid Vaccines
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Recombinant Vaccines
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Conjugate Vaccines
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
7. Global Adult Vaccines Market, By Region, 2017 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, By Region, 2017 and 2025 (%)
? Y-o-Y Growth Analysis, For Region, 2016 - 2025
o North America
? Market Size and Forecast, By Vaccine, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Vaccine Type, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? U.S.
? Canada
o Latin America
? Market Size and Forecast, By Vaccine, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Vaccine Type, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? Brazil
? Mexico
? Argentina
? Rest of Latin America
o Europe
? Market Size and Forecast, By Vaccine, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Vaccine Type, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? Germany
? U.K.
? France
? Italy
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Vaccine, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Vaccine Type, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? China
? India
? Japan
? Australia
? South Korea
? ASEAN
? Rest of APAC
o Middle East
? Market Size and Forecast, By Vaccine, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Vaccine Type, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? GCC
? Israel
? Rest of Middle East
o Africa
? Market Size and Forecast, By Vaccine, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Vaccine Type, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Technology, 2015 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2015 - 2025, (US$ Million)
? South Africa
? Central Africa
? North Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profiles
? GlaxoSmithKline Plc
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
? Merck & Co., Inc.
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
? Sanofi Pasteur
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
? Pfizer, Inc.
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
? CSL Limited
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
? Johnson & Johnson
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
? Serum Institute of India
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
? Medimmune
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
? AstraZeneca Plc
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Performance
? Market Strategies
9. Section
o Analyst Views
10. Section
o References
o Research Methodology
o About Uus and Sales Contact
*Browse 34 market data tables and 38 figures on "Adult Vaccines Market - Global forecast to 2025".
Request Discount 
Inquire Before Buy
